AXSM

Axsome Therapeutics, Inc. - Common Stock (AXSM)

About Axsome Therapeutics, Inc. - Common Stock (AXSM)

Axsome Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which engages in the development of novel therapies for the management of central nervous system disorders. Its portfolio consists of Products Overview and Pipeline Overview. The Products Overview includes Auvelity and Sunosi. The Pipeline Overview refers to AXS-05, AXS-07, AXS-12, and AXS-14. The company was founded by Herriot Tabuteau on January 12, 2012 and is headquartered in New York, NY.

Details

Daily high

$105.41

Daily low

$103.26

Price at open

$103.73

52 Week High

$139.13

52 Week Low

$64.11

Market cap

5.1B

Dividend yield

0.00%

Volume

467,578

Avg. volume

630,674

P/E ratio

-18.09

Axsome Therapeutics, Inc. - Common Stock News